Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 2, 2001, Pages 163-169

  Sabbà, Carlo ^a   Buonamico, Paolo ^a   Vendemiale, Gianluigi ^a   Berardi, Elsa ^a   Antonica, Gianfranco ^a   Palmieri, Vincenzo ^a   Merkel, Carlo ^b   Palasciano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cirrhosis; Doppler ultrasound; Octreotide; Portal hypertension; Propranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OCTREOTIDE; PROPRANOLOL;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DIET RESTRICTION; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; FEMALE; HEMODYNAMICS; HUMAN; HYPEREMIA; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; POSTPRANDIAL STATE; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; VEIN CATHETERIZATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BLOOD FLOW VELOCITY; CATHETERIZATION, PERIPHERAL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FASTING; FEMALE; HEMODYNAMIC PROCESSES; HEPATIC VEINS; HUMANS; HYPEREMIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OCTREOTIDE; PORTAL PRESSURE; POSTPRANDIAL PERIOD; PROPRANOLOL; SPLANCHNIC CIRCULATION; ULTRASONOGRAPHY, DOPPLER; VASOCONSTRICTOR AGENTS;

EID: 0035131638     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200102000-00012     Document Type: Article

References (38)

1. Lebrec D, Hillon P, Munoz C, Goldfarb G, Novel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis. Hepatology 1982; 2: 523-527.
2. Bosch J, Mastai R, Kravetz D, Bruix J, Gaya J, Rigav J. et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 1200-1205.
3. Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981; 305: 1371-1374.
4. Pascal JP, Cales P. Multicenter study group.: Propranolol in the prevention of first gastrointestinal hemorrhage in patients with cirrhosis. N Engl J Med 1988; 319: 8-14.
5. Jenkins SA, Baxter JN, Corbett WA, Shields R. The effects of a somatostatin analogue SMS 201-995 on hepatic hemodynamics in the cirrhotic rats. Br J Surg 1985; 72: 864-867.
6. Jenkins SA, Baxter JN, Corbett WA, Shields R. Effects of SMS 201-995 on hepatic hemodynamics in the pig and on intravariceal pressure in man. Br J Surg 1985; 72: 1009-1012.
7. Han-Chien L, Yang-Te T, Fa-Yah L, Shou-Dong L, Hsiao-Chung H, Wen-Jeh L. et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992; 103: 229-234.
8. Wharen J, Erikson LS. The influence of a long-acting somatostatin analogue on splanchnic hemodynamics and metabolism in healthy subjects and patients with liver cirrhosis. Scand J Gastroenterol 1986; 21: 103-108.
9. Lee SS, Hadengue A, Moreau R, Sayegh R, Hillon P, Lebrec D. Post-prandial hemodynamic response in patients with cirrhosis. Hepatology 1988; 8: 647-651.
10. McCormick PA, Dick R, Graffeo M, Wagstaff D, Madden A, Mcintyre N. et al. The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis. J Hepatol 1990; 11: 221-225.
11. Pugliese D, Ohnishi K, Tsunoda T, Sabbà C, Albano O. Portal hemodynamics after a meal in normal subjects and in patients with chronic liver disease studied by echo-doppler flowmeter. Am J Gastroenterol 1987; 10: 1052-1056.
12. Sabbà C, Ferraioli G, Genecin P, Colombato L, Buonamico P, Lerner E. et al. Evaluation of post-prandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: an operator blind echo-doppler study. Hepatology 1991; 4: 714-717.
13. Bundtsen F, Simonsen L, Henriksen J. Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis. Gastroenterology 1992; 102: 1017-1023.
14. Sabbà C, Ferraioli G, Buonamico P, Mahl T, Taylor KJW, Lerner E. et al. A randomized study of propranolol on post-prandial portal hyperemia in cirrhotic patients. Gastroenterology 1992; 102: 1009-1016.
15. Fara JW. Post-prandial mesenteric hyperemia. In:Physiology of Intestinal Circulation. Shepherd AP, Granger DN (editors). New York: Raven Press; 1984. pp. 99-106.
16. Misumi A, Shiratori K, Lee KJ, Borkin JS, Chey WY. Effects of SMS-201-995, a somatostatin analogue on the exocrine pancreatic secretion and gut hormone release in dogs. Surgery 1988; 103: 450-455.
17. Creutzfield W, Lembcke B, Folsch UR, Schleser S, Koop I. Effects of the somatostatin analogue SMA 201-995 (sandostatin) on pancreatic secretion in humans. Am J Med 1987; 82: 49-54.
18. McCormick PA, Biagini MR, Dick R, Greenslade L, Chin J, Cardin F. et al. Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study. Hepatology 1992; 165: 1180-1186.
19. Buonamico P, Sabbà C, Garcia Tsao G, Berardi E, Antonica G, Ferraioli G. et al. Octreotide blunts post-prandial splanchnic hyperemia in cirrhotic patients; a double-blind randomized echo-doppler study. Hepatology 1995; 21: 134-139.
20. Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS. et al. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol 1989; 9: 326-330.
21. Iwao T, Toyonaga A, Ikegami M, Sumino M, Oho K, Sakaki M. et al. Wedged hepatic venous pressure reflects portal venous pressure during vasoactive drug administration in non-alcoholic cirrhosis. Dig Dis Sci 1994; 39: 2439-2444.
22. Kroeger RJ, Groszmann RJ. Increased portal venous resistances hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985; 5: 97-101.
23. Sabbà C, Ferraioli G, Sarin SK, Lerner E, Groszmann RJ, Taylor KJW. Feasibility spectrum for doppler flowmetry of splanchnic vessels in normal and cirrhotic populations. J Ultrasound Med 1990; 9: 705-710.
24. Sabbà C, Weltin GG, Cicchetti DV, Ferraioli G, Taylor KJW, Nakamura T. et al. Observer variability in echo-doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology 1990; 98: 1603-1611.
25. Gill RW. Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med Biol 1985; 11: 625-641.
26. Moneta GL, Taylor DC, Scott Helton W, Mullholland MW, Strandness DE. Duplex ultrasound measurement of post-prandial intestinal blood flow: effect of meal composition. Gastroenterology 1988; 95: 1294-1301.
27. Gaiani S, Bolondi L, Li Bassi L, Santi V, Zironi G, Barbara L. Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology 1989; 8: 815-819.
28. Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H. et al. Clinical application of an ultrasonic duplex system in the quantitative measurements of portal blood flow. J Clin Ultrasound 1986; 14: 579-588.
29. Arthur MJSP, Tanner AR, Wright R, Renwick AG, George CF. Pharmacology of propranolol in patients with cirrhosis and portal hypertension. Gut 1985; 26: 14.
30. Sabbà C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D. et al. Interobserver and inter-equipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995; 21: 428-433.
31. Zoli M, Merkel C, Sabbà C, Sacerdoti D, Gaiani S, Ferraioli G. et al. Interobserver and inter-equipment variability of echo-doppler evaluation of the superior mesenteric artery. J Clin Ultrasound 1996; 15: 99-106.
32. Sabbà C, Ferraioli G, Buonamico P, Berardi E, Antonica G, Taylor KJW. et al. Echo-doppler evaluation of acute flow changes in portal hypertensive patients: flow velocity as a reliable parameter. J Hepatol 1992; 15: 356-360.
33. Gosling RG, Dunbar G, King DH, Newman DL, Side CD, Wodcock JP. et al. The quantitative analysis of occlusive peripheral arterial disease by a non-intrusive ultrasonic technique. Angiology 1971; 22: 52-55.
34. Kravetz D, Bosch J, Arderiu MT, Pizcueta MP, Casamityana R, Rivera F. et al. Effect of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol 1988; 254: G322-G328.
35. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 1981; 80: 518-525.
36. Samnegard H, Tulin L, Andreen M, Tyden G, Hallberg D, Efendic S. Circulatory effects of somatostatin in anesthetized dogs. Acta Chir Scand 1979; 145: 209-213.
37. Jenkins SA, Devitt P, Day DW, Baxter JN, Shields R. Effect of somatostatin on hepatic hemodynamics in cirrhotic rats. Digestion 1983; 33: 126-134.
38. Tornebrandt K, Owman CH. Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides 1987; 8: 251-256.